– Selection of lead compound for AM-102 program planned for 2017 ZUG, Switzerland, Feb. 22, 2017 (GLOBE NEWSWIRE) — AurisREAD MORE…
At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.
Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.
SEATTLE, Feb. 22, 2017 – Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients andREAD MORE…
Updates on clinical development of JBT-101 and presentation of new pre-clinical and MOA data; Live video webcast on March 13thREAD MORE…